| 查看: 2138 | 回复: 10 | |||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | |||
wfl09铁杆木虫 (职业作家)
Mr
|
[交流]
澳洲医学奖学金phd机会，年薪35000澳元外加旅游经费，开会补助，免学费已有6人参与
|
||
|
Dear Researcher A new scholarship opportunity exists for PhD candidates in south western Sydney. Please forward details to any potential candidates who may be interested. South Western Sydney Local Health District, UNSW and Ingham Institute for Applied Medical Research PhD Scholarship: Use of a Decision Aid in Ulcerative Colitis: Enhancing Patients’ Empowerment, Quality of Life and Disease Control. Scholarship Description The scholarship is for the PhD project: “Use of A Decision Aid in Ulcerative Colitis: Enhancing Patients’ Empowerment, Quality of Life and Disease Control”, funded through South Western Sydney Local Health District (SWSLHD). The value of the scholarship is AU$35000 per annum for 3 years plus travel expenses required for implementation of the project and additional financial support enabling the candidate to attend one annual Australian Gastroenterology scientific meeting during the course of their study. Project Description At least 77000 Australians are affected by inflammatory bowel disease (IBD), a chronic inflammatory disease of the gastrointestinal tract, which includes both Crohn’s Disease (CD) and Ulcerative Colitis (UC). The vast majority of IBD patients want Shared Decision Making (SDM) as the model for IBD care. Decision aids support and promote SDM. The first decision aid worldwide for use in UC has been developed by the IBD Research Group at Liverpool Hospital in collaboration with Associate Professor Corey Siegel, Director of Dartmouth-Hitchcock IBD Centre, Lebanon, NH, USA and Professor Afaf Girgis Director of Psycho-Oncology Research Group at the Ingham Institute for Applied Medical Research. Design of this web-based tool was based on survey results from 460 UC patients in both USA and Australia with refinement of the decision aid (DA) following feedback by UC patients and review by leading IBD experts. The DA addresses patient concerns around the diagnosis and complications of UC including colorectal cancer; the types of medical treatments available for UC and patient fears of treatment related adverse events, in particular cancer; and finally possible surgical treatment options for UC and the associated pros and cons. A stepped wedge trial (SWT) will be conducted to test the implementation of the UC decision aid versus standard care in clinical practice. This initial trial will include four sites within Sydney over three years, with expansion to a national trial anticipated. Primary outcomes measures will include Patient Empowerment and Patient Quality of Life. Secondary outcome measures will include Medication Adherence, UC Disease Activity, Unplanned Hospital Admissions and Anxiety and Depression. Acceptability of the DA will also be assessed. The candidate for this PhD project will conduct the NSW arm of this SWT. The candidate will develop strong experience in undertaking translational research in the clinical setting, including evaluation of the implementation of a DA and its translation into clinical practice. Pending results of this trial, it is anticipated that this UCDA may become a daily tool for use in the management of UC. The successful PhD candidate will be enrolled in the South Western Sydney Clinical School, UNSW Medicine, UNSW; and located at the Ingham Institute for Applied Medical Research in Liverpool, Sydney. This innovative independent not-for-profit research organisation houses approximately 200 researchers and has a primary focus on translational research. It is strategically well-placed through co-location with the Liverpool Hospital, the biggest in Australia, and close links to other hospitals in the Sydney South West and partnering with SWSLHD, UNSW and UWS. The student will be co-supervised by Susan Connor, Senior Staff Specialist, Department of Gastroenterology & Hepatology, Liverpool Hospital; and Professor Afaf Girgis, Director, Psycho-oncology Research Group, Centre for Oncology Education and Research Translation (CONCERT), Ingham Institute for Applied Medical Research & UNSW, with access to world-class research facilities and expertise. Collaboration with Associate Professor Corey Siegel, well recognised for his work on SDM in IBD, will also continue during this project, providing further links internationally. Payment Information The value of this scholarship is AUD$35000 per annum for a period of 3 years. This does not include travel expenses required for implementation of the project nor additional financial support to attend one annual Australian Gastroenterology scientific meeting during the course of study. More information and application details are available at: https://swscs.med.unsw.edu.au/po ... -ulcerative-colitis Regards Craig |
回复此楼» 猜你喜欢
英国曼彻斯特大学石墨烯研究所博士生招生
已经有0人回复
-
电子信息方向博士申请
已经有0人回复
-
半导体科学与信息器件论文润色/翻译怎么收费?
已经有72人回复
-
需求和任务如何关联
已经有0人回复
-
紧急名额 厦门大学 有兴趣攻读半导体器件/核酸自组装 2026年秋季博士/硕士方向
已经有12人回复
-
青岛大学应届硕士2026博士申请（替朋友发帖）
已经有0人回复
-
材料工程/微电子方向相关/26年申请博士
已经有5人回复
-
上海交通大学纳米器件和材料研究组招聘博士生
已经有1人回复
-
上海交通大学纳米器件和材料研究组招聘教师和博士后
已经有0人回复
» 本主题相关价值贴推荐，对您同样有帮助:
我想问问我这样的条件可以申请哪些北美学校呀？
已经有9人回复
| 祝福 |
10楼2015-02-05 19:07:10